Nasdaq
BTAI
BioXcel Therapeutics, Inc.
- Health Care
- Listed 2018
- 1 day
- −1.2%
- 1 month
- −20.2%
- 1 year
- −75.0%
$0.8302 · Mkt cap $25.6M
At the 6 Aug 2026 close
Nasdaq
BioXcel Therapeutics, Inc.
$0.8302 · Mkt cap $25.6M
At the 6 Aug 2026 close
BioXcel Therapeutics, Inc. trades under the ticker BTAI on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2018. Its market capitalisation is $25.6M. The last closing price was $0.8302, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −75.0%, and −20.2% over the past month. Returns are price returns and exclude dividends.
This page exists because BTAI is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.